BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 249 filers reported holding BLUEBIRD BIO INC in Q3 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $374,000 | -6.7% | 90,105 | +124.4% | 0.41% | +2.0% |
| Q4 2021 | $401,000 | -43.2% | 40,145 | +8.7% | 0.40% | -24.4% |
| Q3 2021 | $706,000 | -49.1% | 36,919 | -15.0% | 0.53% | -48.4% |
| Q2 2021 | $1,387,000 | +28.4% | 43,412 | +15.1% | 1.02% | +97.3% |
| Q1 2021 | $1,080,000 | +64.9% | 37,712 | +504.8% | 0.52% | -15.6% |
| Q2 2017 | $655,000 | +87.7% | 6,235 | +52.7% | 0.62% | -72.0% |
| Q3 2015 | $349,000 | – | 4,084 | – | 2.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |